Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • inderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Följda bolag
    • Teamet
Pressmeddelande

aXichem AB: aXichem's CEO Torsten Helsing Presents the Report for the Second Quarter 2025 in a Live Web Conference

aXichem

aXichem AB (publ), publishes its report for the second quarter 2025 on Thursday, 28 August 2025. The same day at 2:00 p.m., the company invites you to a live web conference with CEO Torsten Helsing.

After the conference, there will be a question-and-answer session. Please note that the presentation is held in Swedish. It is possible to follow the conference via computer or mobile devices.

To register for the web conference, please register via the following link:

https://us06web.zoom.us/webinar/register/WN_2RlQI66rRvm7PzMxw_Gk_A


The number of seats is limited, so we recommend registering well in advance to secure a seat.

After the conference, the teleconference and the presentation material will be available on the company's website, www.aXichem.com and on the Västra Hamnen Corporate Finance channel on YouTube.

The information was submitted, through the care of the contact person below, for publication on
25 August 2025, at 11:00 AM CET.

Company contact:
Torsten Helsing, CEO, aXichem AB
Phone: +46 706 863 355 Email: torsten.helsing@axichem.com

About aXichem
aXichem develops, patents and markets natural analogue industrial chemicals, i.e., synthetically produced substances that have similar and comparable properties to natural substances. The company's first product is phenylcapsaicin, which the company commercializes under two brands, aXiphen® and aXivite®, as an ingredient in animal feed and dietary supplements, respectively. The business is divided into three market areas with different applications for phenylcapsaicin: as an ingredient in feed for poultry, such as chicken and turkey; as an ingredient in food supplements for gut health, weight control and sports and exercise; and as an ingredient in food supplements for the bio- enhancement of curcumin and melatonin. aXichem is listed on the Nasdaq First North Growth Market. Certified advisor for aXichem is Västra Hamnen Corporate Finance AB. More information is available at www.axichem.com.

Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.